Institute of Biomedical Engineering, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, China.
Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310020, China.
Cardiovasc Res. 2023 Jul 6;119(8):1656-1675. doi: 10.1093/cvr/cvad076.
Cardiovascular disease (CVD) is a serious health challenge, causing more deaths worldwide than cancer. The vascular endothelium, which forms the inner lining of blood vessels, plays a central role in maintaining vascular integrity and homeostasis and is in direct contact with the blood flow. Research over the past century has shown that mechanical perturbations of the vascular wall contribute to the formation and progression of atherosclerosis. While the straight part of the artery is exposed to sustained laminar flow and physiological high shear stress, flow near branch points or in curved vessels can exhibit 'disturbed' flow. Clinical studies as well as carefully controlled in vitro analyses have confirmed that these regions of disturbed flow, which can include low shear stress, recirculation, oscillation, or lateral flow, are preferential sites of atherosclerotic lesion formation. Because of their critical role in blood flow homeostasis, vascular endothelial cells (ECs) have mechanosensory mechanisms that allow them to react rapidly to changes in mechanical forces, and to execute context-specific adaptive responses to modulate EC functions. This review summarizes the current understanding of endothelial mechanobiology, which can guide the identification of new therapeutic targets to slow or reverse the progression of atherosclerosis.
心血管疾病(CVD)是一个严重的健康挑战,在全球范围内导致的死亡人数超过癌症。血管内皮细胞形成血管的内层,在维持血管完整性和内稳态方面起着核心作用,并且与血流直接接触。过去一个世纪的研究表明,血管壁的机械扰动有助于动脉粥样硬化的形成和发展。虽然动脉的直段暴露于持续的层流和生理高剪切力,但分支点附近或弯曲血管中的血流可能表现出“紊乱”的流动。临床研究以及精心控制的体外分析证实,这些紊乱流动的区域,包括低剪切力、再循环、振荡或侧向流动,是动脉粥样硬化病变形成的优选部位。由于它们在血流稳态中的关键作用,血管内皮细胞(EC)具有机械感受器机制,使它们能够快速对机械力的变化作出反应,并执行特定于上下文的适应性反应来调节 EC 功能。这篇综述总结了目前对内皮细胞力学的理解,这可以指导识别新的治疗靶点,以减缓或逆转动脉粥样硬化的进展。